ReviewJournal of acquired immune deficiency syndromes (1999)2010
Progress in HIV reduction and prevention among injection and noninjection drug users.
Review in Journal of acquired immune deficiency syndromes (1999), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.American journal of public health · 2013Pooled it
- Translation of basic research in cognitive science to HIV-risk: a randomized controlled trial.Journal of behavioral medicine · 2019Trial
- Trial
- Trial
- Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users.Health education & behavior : the official publication of the Society for Public Health Education · 2014Trial
- Injection and Non-Injection Drug Use Among Adults with Diagnosed HIV in the United States, 2015-2018.AIDS and behavior · 2022Article
- Associating conditional cash transfer to universal access to treatment could be the solution to the HCV epidemic among drug users (DUs).Harm reduction journal · 2018Article
- Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009.Journal of acquired immune deficiency syndromes (1999) · 2017Article
- Predictive utility and measurement properties of the Strength of Implementation Intentions Scale (SIIS) for condom use.Social science & medicine (1982) · 2017Article
- Individual and Neighborhood Characteristics Associated with HIV Among Black and Latino Adults Who Use Drugs and Unaware of Their HIV-Positive Status, New York City, 2000-2004.Journal of racial and ethnic health disparities · 2016Article
- Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.AIDS and behavior · 2015Article
- Tailored combination prevention packages and PrEP for young key populations.Journal of the International AIDS Society · 2015Article
- Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).Infectious disease clinics of North America · 2014Review
- The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.Drug and alcohol dependence · 2014Article
- Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009.AIDS and behavior · 2014Article
- The relationship between discrimination and high-risk social ties by race/ethnicity: examining social pathways of HIV risk.Journal of urban health : bulletin of the New York Academy of Medicine · 2014Article
- HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.Journal of the International AIDS Society · 2014Review
- Latent class analysis of polysubstance use, sexual risk behaviors, and infectious disease among South African drug users.Drug and alcohol dependence · 2013Article
- Combination prevention: new hope for stopping the epidemic.Current HIV/AIDS reports · 2013Review
- Drug users in Amsterdam: are they still at risk for HIV?PloS one · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Substantial progress has been made in reducing HIV among injection drug users (IDUs) in the United States, despite political and social resistance that reduced resources and restricted access to services. The record for HIV prevention among noninjecting drug users is less developed, although they are more numerous than IDUs. Newer treatments for opiate and alcohol abuse can now be integrated into primary HIV care; treatment for stimulant abuse is less developed. All drug users present challenges for newer HIV prevention strategies (eg, "test and treat," nonoccupational postexposure prophylaxis and preexposure prophylaxis, contingency management, and conditional cash transfer). A comprehensive HIV prevention program that includes multicomponent multilevel approaches (ie, individual, network, structural) has been effective in HIV prevention among IDUs. Expanding these approaches to noninjecting drug users, especially those at highest risk (eg, minority men who have sex with men) and incorporating these newer approaches is a public health priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.